Terns Pharmaceuticals, Inc. (TERN)
USD 5.76
(-15.29%)
USD 5.76
(-15.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -67.73 Million | -49.1 Million | -41.82 Million | -29.8 Million | -66.22 Million | -18.07 Million |
| Net Income | -90.21 Million | -60.34 Million | -50.15 Million | -40.57 Million | -68.81 Million | -18.01 Million |
| Depreciation & Amortization | 881 Thousand | 1.03 Million | 512 Thousand | 394 Thousand | 195 Thousand | 65 Thousand |
| Deferred income taxes | 141 Thousand | 392 Thousand | 219 Thousand | 693 Thousand | 206 Thousand | 307 Thousand |
| Stock-based compensation | 25.53 Million | 10.76 Million | 8.14 Million | 1.69 Million | 668 Thousand | 234 Thousand |
| Change in working capital | 1.29 Million | -1.03 Million | -1.42 Million | 5.06 Million | 1.77 Million | -352 Thousand |
| Other non-cash items | -5.37 Million | 81 Thousand | 879 Thousand | 2.92 Million | -246 Thousand | -307 Thousand |
| Investing Cash Flow | -37.98 Million | -22.27 Million | -119.69 Million | 6.69 Million | -3.85 Million | -4.77 Million |
| Investments in PPE | -52 Thousand | -275 Thousand | -340 Thousand | -584 Thousand | -900 Thousand | -244 Thousand |
| Acquisitions | 37.93 Thousand | 21.99 Thousand | 119.35 Thousand | -7277.00 | 2956.00 | 12.04 Million |
| Investment purchases | -275.78 Million | -139.73 Million | -166.29 Million | -715 Thousand | -58.38 Million | -6.94 Million |
| Sales/Maturities of investments | 237.84 Million | 117.73 Million | 46.94 Million | 7.99 Million | 55.42 Million | 2.41 Million |
| Other Investing Activities | -37.93 Thousand | -21.99 Thousand | -119.35 Thousand | 7277.00 | -2956.00 | -4532.00 |
| Financing Cash Flow | 42.29 Million | 167.49 Million | 134.39 Million | 85.51 Million | 62 Thousand | 99.76 Million |
| Debt repayment | - | - | -12.88 Million | -16.87 Million | -58 Thousand | -58 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 410 Thousand | 243 Thousand | - | - | - | - |
| Common Stock Issuance | 42.29 Million | 167.49 Million | 136.36 Million | 69.37 Million | 26 Thousand | 87.66 Million |
| Other Financing Activities | -344 Thousand | -401 Thousand | 10.91 Million | 33.01 Million | 94 Thousand | 99.76 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.14 Million | -722 Thousand | 1.72 Million | -1.14 Million | 722 Thousand | 488 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 142 Thousand | -315 Thousand | -3.15 Million | 6.2 Million | 1.05 Million | -840 Thousand |
| Cash at beginning of period | 143.23 Million | 47.69 Million | 74.85 Million | 12.37 Million | 82.52 Million | 5.5 Million |
| Cash at end of period | 79.92 Million | 143.23 Million | 47.69 Million | 74.85 Million | 12.37 Million | 82.52 Million |
| Capital Expenditure | -52 Thousand | -275 Thousand | -340 Thousand | -584 Thousand | -900 Thousand | -244 Thousand |
| Effect of forex changes on cash | 117 Thousand | -178 Thousand | -25 Thousand | 80 Thousand | -131 Thousand | 103 Thousand |
| Net cash flow / Change in cash | -63.3 Million | 95.53 Million | -27.15 Million | 62.47 Million | -70.14 Million | 77.01 Million |
| Free Cash Flow | -67.78 Million | -49.38 Million | -42.16 Million | -30.39 Million | -67.12 Million | -18.31 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -22.73 Million | -22.37 Million | -90.21 Million | -21.01 Million | -29.76 Million | -17.89 Million |
| Depreciation & Amortization | 240 Thousand | 236 Thousand | 881 Thousand | 220 Thousand | 222 Thousand | 217 Thousand |
| Deferred income taxes | 34 Thousand | 34 Thousand | 141 Thousand | 45 Thousand | 32 Thousand | 32 Thousand |
| Stock-based compensation | 4.42 Million | 4.02 Million | 25.53 Million | 3.28 Million | 14.08 Million | 4.23 Million |
| Change in working capital | 2.42 Million | -4.36 Million | 1.29 Million | -345 Thousand | -3.52 Million | 1.39 Million |
| Other non-cash items | 4.16 Million | 4.95 Million | -5.37 Million | -1.49 Million | -1.74 Million | -975 Thousand |
| Investing Cash Flow | 42.19 Million | 7.99 Million | -37.98 Million | 47.23 Million | -22.31 Million | -90.83 Million |
| Investments in PPE | -13 Thousand | -29 Thousand | -52 Thousand | -44 Thousand | -8000.00 | - |
| Acquisitions | - | - | 37.93 Thousand | -47.27 Thousand | 22.3 Thousand | - |
| Investment purchases | - | -50.59 Million | -275.78 Million | -5.01 Million | -64.07 Million | -182.83 Million |
| Sales/Maturities of investments | 42.2 Million | 58.62 Million | 237.84 Million | 52.29 Million | 41.76 Million | 91.99 Million |
| Other Investing Activities | 42.2 Thousand | 8.02 Million | -37.93 Thousand | 47.27 Thousand | -22.3 Thousand | -90.83 Thousand |
| Financing Cash Flow | 399 Thousand | - | 42.29 Million | 13.86 Million | 20 Thousand | 489 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 410 Thousand | 410 Thousand | - | - |
| Common Stock Issuance | 399 Thousand | - | 42.29 Million | 13.86 Million | 20 Thousand | 489 Thousand |
| Other Financing Activities | 399.00 | - | -344 Thousand | 13.86 Million | 20 Thousand | 489 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 172 Thousand | -814 Thousand | 1.14 Million | -810 Thousand | -2.21 Million | 2.84 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.25 Million | -3.54 Million | 142 Thousand | 465 Thousand | -1.3 Million | -1.45 Million |
| Cash at beginning of period | 65.09 Million | 79.92 Million | 143.23 Million | 37.89 Million | 80.91 Million | 184.35 Million |
| Cash at end of period | 91.49 Million | 65.09 Million | 79.92 Million | 79.92 Million | 37.89 Million | 80.91 Million |
| Capital Expenditure | -13 Thousand | -29 Thousand | -52 Thousand | -44 Thousand | -8000.00 | - |
| Effect of forex changes on cash | -14 Thousand | -26 Thousand | 117 Thousand | 255 Thousand | -34 Thousand | -94 Thousand |
| Net cash flow / Change in cash | 26.39 Million | -14.82 Million | -63.3 Million | 42.03 Million | -43.02 Million | -103.43 Million |
| Free Cash Flow | -16.19 Million | -22.82 Million | -67.78 Million | -19.36 Million | -20.7 Million | -12.99 Million |
GNRS
IKTIN
JAIPAN
FTREIT
AUTOAXLES
600807